-
Mesothelioma Victim’s Journey Profiled on National News Website
Most people’s familiarity with malignant mesothelioma comes from late-night television ads urging victims to contact attorneys, but thanks to a Yahoo.com profile on survivor Heath Von St. James, the rare and fatal form of cancer is getting a big boost of attention.
-
Asbestos Company’s Appeal of Mesothelioma Verdict Backfires, Leads to Larger Award
It is not at all unusual for an asbestos company ordered to pay a large mesothelioma award to file an appeal of the jury’s verdict, and that is exactly what talc provider Whittaker, Clark and Daniels, Inc. did when faced with a $3 million award to the estate of a peritoneal mesothelioma victim and her
-
Trane Technologies’ Companies Placed in Bankruptcy Due to Mesothelioma Filings
Over the years, dozens of asbestos companies have filed for bankruptcy in response to overwhelming liability to mesothelioma victims and others harmed by exposure to asbestos, and now another has joined their ranks. Trane Technologies PLC, a company with a history of selling asbestos-contaminated pumps, compressors, and HVAC equipment, announced that two newly created business
-
White Female Mesothelioma Patients May Be At Higher Risk for Depression
Though the primary concern when a person is diagnosed with malignant mesothelioma is their physical health, it is essential that clinicians, caretakers and family members pay close attention to the patient’s psychological wellbeing too. A recent study conducted at the University of Florida looked at cancer patients’ vulnerability to depression, and found that though among
-
Near-Infrared Irradiation Shows Promise in Treatment of Malignant Mesothelioma
Surgery, chemotherapy and radiation therapy are three of the top treatments for malignant mesothelioma, and research is suggesting that immunotherapy may soon be added to the list, but now scientists from Nagoya University are adding another potential tool to oncologists’ toolbox: they say that tests of near-infrared irradiation combined with a cancer-targeting compound have been
-
Study Reveals Greater Accuracy of MRI In Assessing Peritoneal Mesothelioma
Whether you’ve been diagnosed with malignant pleural mesothelioma or malignant peritoneal mesothelioma, having an accurate assessment of the extent of your disease is essential to creating the most effective treatment plan. A new study has revealed that when it comes to peritoneal mesothelioma, MRI provides a more accurate picture of how far the disease has
-
Court Denies Electrical Manufacturers’ Cigarette Warning Argument in Asbestos Lung Cancer Lawsuit
When mesothelioma and asbestos lung cancer victims file lawsuits against those responsible for their illness, their attorneys warn them to expect the worst from the asbestos companies and those companies’ attorneys. Just as the companies put profits over people when they exposed workers to asbestos-contaminated products, they will say and do almost anything to avoid
-
FDA Provides Approval of Keytruda For Treatment of Mesothelioma and Other Tumors
Following confirmation of positive results, the U.S. Food and Drug Administration has approved the use of the immunotherapy drug pembrolizumab (Keytruda) for patients diagnosed with unresectable or metastatic malignant mesothelioma, as well as other solid tumor cancers.
-
Study Reveals Weakness of Video-Assisted Pleural Biopsy for Mesothelioma Diagnosis
When a patient is suspected of having malignant pleural mesothelioma, speed is of the essence. The physician’s goal is to confirm the diagnosis as quickly as possible so that they can devise the most effective treatment protocol for the patient’s specific condition. One of the most frequently-used tools in staging this rare and fatal form
-
NYC Pollution Control Engineer’s Mesothelioma Lawsuit Survives Boiler Company’s Objections
When New York City pollution control engineer Thomas L. Eckrich was diagnosed with malignant mesothelioma, he was initially uncertain as to how he could have contracted the disease, as his job did not involve him working with asbestos or any asbestos-contaminated products. It was only after careful review of his work environment that he realized
-
Study Reveals Significant Benefit for Mesothelioma Patients from Novel Chemotherapy Treatment
This year’s Society of Interventional Radiology’s Annual Scientific Meeting may have had to be held virtually, but the information delivered for mesothelioma patients was very real and very significant. Speaking to the group about their novel treatment for advanced mesothelioma, Bela Kis, M.D., PhD of the Moffitt Cancer Center in Tampa revealed an extended survival
-
Japanese High Court Blames Mesothelioma and Other Asbestos-Related Diseases on Mishandling of Asbestos
Workers in the United States are not alone in having been negligently exposed to asbestos and falling victim to malignant mesothelioma. Mesothelioma is a global problem, and though America has a reputation for being overly litigious, courts around the world are starting to follow the same path of ordering asbestos companies to pay significant damage
-
EPA Science Advisory Committee Critical of Asbestos Draft
It is well known that exposure to asbestos causes malignant mesothelioma, asbestosis, and asbestos-related lung cancer. But the deadly material is also responsible for a host of other illnesses, and the EPA’s failure to address both these illnesses and many possible sources of occupational exposure to asbestos is being roundly criticized by its own internal
-
Italian Study Reveals Multiple Benefits to Team Approach to Mesothelioma
It is an unfortunate truth that in the United States and around the world, patients with malignant mesothelioma do not all receive the same level of care. There have been multiple studies documenting the differences and their causes. Some have to do with patients’ age or proximity to state-of-the-art cancer centers. Some have to do
-
Study’s Findings on Neuropathy May Benefit Mesothelioma Patients
Patients with malignant mesothelioma suffer innumerable discomforts and adverse effects from both the disease itself and the treatments physicians use to prolong their lives. Among the most painful of these is neuropathy. Now researchers from Georgia Tech believe that they’ve arrived at a better understanding of what causes neuropathy, and hope that it will yield an effective
-
Memorial Sloan Kettering Researchers Report Success in Controlling Stubborn Mesothelioma Tumors
For more than two years, researchers from the renowned Memorial Sloan Kettering Cancer Center in New York have been studying whether the cancer drug Tazemotostat could inhibit the growth of malignant mesothelioma tumors. At the 2020 ASCO Annual Meeting, they presented data showing that it successfully inactivated the effect of the BAP1 gene mutation and
-
Japanese Study Reveals Vital Data Regarding Common Mesothelioma Surgery
Patients with malignant pleural mesothelioma go through a rigorous staging and assessment protocol once their cancer has been diagnosed. The goal is to determine how advanced their cancer is, what their overall health status is and where the tumors are so that the best possible treatment plan can be put in place. One of the
-
NJ Supreme Court Places Mesothelioma Liability for Replacement Parts on Original Manufacturers
For years, manufacturers of automobiles and other pieces of equipment requiring replacement parts have denied their responsibility for malignant mesothelioma caused by asbestos in replacement parts for their equipment. They have pointed to the parts manufacturers and tried to wash their hands of responsibility despite the fact that their equipment required those parts to continue
-
Court Denies Crane’s Motion to Dismiss Maritime Laws in Mesothelioma Claim
There’s little question that Navy veteran Herbert H. Mullinex’s malignant mesothelioma comes from exposure to asbestos during his service. He worked on several ships doing shipbuilding and repair. In suing John Crane, Inc., he did so under both federal and maritime law. Though the company has not argued that their product was not responsible, they
-
ASCO20 Virtual Scientific Program Continues to Reveal Progress in Mesothelioma Treatment
This year’s American Society of Clinical Oncology’s meeting had to be held virtually in light of the global pandemic, but that has in no way interfered with the revelations of remarkable progress in the treatment of malignant pleural mesothelioma. Among the presentations was news that Italian researchers have significantly improved survival among mesothelioma patients by treating
